Abstract
It has previously been suggested that keratinocytes might provide a suitable target cell for delivery of factor IX to the systemic circulation for gene therapy of haemophilia B. Here, an investigation of the use of cellular gene promoters specific for keratinocytes was undertaken to examine whether factor IX could be passed from the epidermis to the systemic circulation. Utilizing two bovine cytokeratin gene promoters, BKIII and BKVI, three lines of transgenic mice were generated with targeted expression of human factor IX in the epidermis. All three transgenic mouse lines secreted epidermally derived human factor IX into the blood system. Most effective factor IX expression (46 ng/ml steady-state levels of circulating human factor IX) was obtained utilizing the BKVI gene promoter, the human homologue of K10, which is expressed exclusively in differentiated keratinocytes, localized distal to the basement membrane. This report demonstrates, for the first time, that human factor IX can be efficiently synthesized and secreted from keratinocytes in situ, and can cross the epidermal basement membrane to reach the systemic circulation. The transgenic mouse model will provide a good in vivo system with which to optimize the efficiency...Continue Reading
Citations
Feb 7, 2001·The Journal of Gene Medicine·H SchneiderC Coutelle
Apr 17, 2010·Applied Biochemistry and Biotechnology·Seyed Javad HosseiniFariba Ataei
Jun 14, 2002·Academic Radiology·Peter VaradyGregory A Helm
Dec 3, 1999·International Journal of Dermatology·M BraddockD Zuder
Jun 3, 1999·Proceedings of the Association of American Physicians·L B Taichman
Sep 17, 1996·Proceedings of the National Academy of Sciences of the United States of America·M B MathorM De Luca
Nov 21, 2000·Human Gene Therapy·T CaoD R Roop
Jun 18, 2002·Human Gene Therapy·Tongyu CaoDennis R Roop
May 1, 1997·Human Gene Therapy·N Miller, J Whelan
Jun 13, 1998·Human Gene Therapy·S J WhiteG G Brownlee
Sep 10, 2013·PloS One·Siqi GuoRichard Heller
Jan 7, 1997·Proceedings of the National Academy of Sciences of the United States of America·X WangE Fuchs
Dec 10, 1996·Proceedings of the National Academy of Sciences of the United States of America·K Takahashi, P A Coulombe
Jun 4, 2004·Expert Opinion on Biological Therapy·Steven S Fakharzadeh
Nov 6, 2009·Experimental Dermatology·Frank ScheidemannWolfgang Pfützner
Sep 14, 2000·Molecular Therapy : the Journal of the American Society of Gene Therapy·U R Hengge, A Mirmohammadsadegh
Feb 13, 2001·Molecular Therapy : the Journal of the American Society of Gene Therapy·D WolfeJ C Glorioso
Jun 1, 2005·Molecular Therapy : the Journal of the American Society of Gene Therapy·Bharat G BajajStelios T Andreadis
Jul 5, 2005·Arteriosclerosis, Thrombosis, and Vascular Biology·M Yvonne AlexanderAnn E Canfield
Jun 28, 2001·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·F LarcherJ L Jorcano
Mar 20, 1999·The Journal of Investigative Dermatology·W H YuR J Debs
Aug 1, 1997·The Journal of Investigative Dermatology·S M Page, G G Brownlee